PTK2 and gallbladder cancer: In this study, we firstly show evidence that NCTD inhibits tumor VM and prolongs host survival in highly aggressive gallbladder cancers via blocking the EphA2/FAK/Paxillin signaling pathway, thus may serve as a potential target inhibitor for VM of highly aggressive gallbladder cancers.